Medical Care
Global IVD Infectious Disease Market Research Report 2024
- Jan 26, 24
- ID: 25204
- Pages: 89
- Figures: 171
- Views: 26
In Vitro Diagnosis, or IVD (In Vitro Diagnosis), refers to the product and service of disease or body function that is obtained by testing human samples (blood, body fluids, tissues, etc.).
The global IVD Infectious Disease market was valued at US$ 4364 million in 2023 and is anticipated to reach US$ 7765.1 million by 2030, witnessing a CAGR of 8.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for IVD Infectious Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVD Infectious Disease.
Report Scope
The IVD Infectious Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global IVD Infectious Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IVD Infectious Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Diagnostics
Abbott Laboratories
Gen-Probe
Becton Dickinson (BD)
Bio-Rad Laboratories
Siemens Healthcare
Biomérieux
Danaher
Thermo Fisher
Sysmex
Segment by Type
Biochemical Diagnosis
Immune Diagnosis
Molecular Diagnosis
Microbiological Diagnosis
Urine Diagnosis
Coagulation Diagnosis
Other
Segment by Application
Personal
Commercial
Academic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IVD Infectious Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global IVD Infectious Disease market was valued at US$ 4364 million in 2023 and is anticipated to reach US$ 7765.1 million by 2030, witnessing a CAGR of 8.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for IVD Infectious Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVD Infectious Disease.
Report Scope
The IVD Infectious Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global IVD Infectious Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IVD Infectious Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Diagnostics
Abbott Laboratories
Gen-Probe
Becton Dickinson (BD)
Bio-Rad Laboratories
Siemens Healthcare
Biomérieux
Danaher
Thermo Fisher
Sysmex
Segment by Type
Biochemical Diagnosis
Immune Diagnosis
Molecular Diagnosis
Microbiological Diagnosis
Urine Diagnosis
Coagulation Diagnosis
Other
Segment by Application
Personal
Commercial
Academic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IVD Infectious Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IVD Infectious Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Biochemical Diagnosis
1.2.3 Immune Diagnosis
1.2.4 Molecular Diagnosis
1.2.5 Microbiological Diagnosis
1.2.6 Urine Diagnosis
1.2.7 Coagulation Diagnosis
1.2.8 Other
1.3 Market by Application
1.3.1 Global IVD Infectious Disease Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Personal
1.3.3 Commercial
1.3.4 Academic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global IVD Infectious Disease Market Perspective (2019-2030)
2.2 IVD Infectious Disease Growth Trends by Region
2.2.1 Global IVD Infectious Disease Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 IVD Infectious Disease Historic Market Size by Region (2019-2024)
2.2.3 IVD Infectious Disease Forecasted Market Size by Region (2025-2030)
2.3 IVD Infectious Disease Market Dynamics
2.3.1 IVD Infectious Disease Industry Trends
2.3.2 IVD Infectious Disease Market Drivers
2.3.3 IVD Infectious Disease Market Challenges
2.3.4 IVD Infectious Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IVD Infectious Disease Players by Revenue
3.1.1 Global Top IVD Infectious Disease Players by Revenue (2019-2024)
3.1.2 Global IVD Infectious Disease Revenue Market Share by Players (2019-2024)
3.2 Global IVD Infectious Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by IVD Infectious Disease Revenue
3.4 Global IVD Infectious Disease Market Concentration Ratio
3.4.1 Global IVD Infectious Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IVD Infectious Disease Revenue in 2023
3.5 IVD Infectious Disease Key Players Head office and Area Served
3.6 Key Players IVD Infectious Disease Product Solution and Service
3.7 Date of Enter into IVD Infectious Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IVD Infectious Disease Breakdown Data by Type
4.1 Global IVD Infectious Disease Historic Market Size by Type (2019-2024)
4.2 Global IVD Infectious Disease Forecasted Market Size by Type (2025-2030)
5 IVD Infectious Disease Breakdown Data by Application
5.1 Global IVD Infectious Disease Historic Market Size by Application (2019-2024)
5.2 Global IVD Infectious Disease Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America IVD Infectious Disease Market Size (2019-2030)
6.2 North America IVD Infectious Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America IVD Infectious Disease Market Size by Country (2019-2024)
6.4 North America IVD Infectious Disease Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe IVD Infectious Disease Market Size (2019-2030)
7.2 Europe IVD Infectious Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe IVD Infectious Disease Market Size by Country (2019-2024)
7.4 Europe IVD Infectious Disease Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific IVD Infectious Disease Market Size (2019-2030)
8.2 Asia-Pacific IVD Infectious Disease Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific IVD Infectious Disease Market Size by Region (2019-2024)
8.4 Asia-Pacific IVD Infectious Disease Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America IVD Infectious Disease Market Size (2019-2030)
9.2 Latin America IVD Infectious Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America IVD Infectious Disease Market Size by Country (2019-2024)
9.4 Latin America IVD Infectious Disease Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IVD Infectious Disease Market Size (2019-2030)
10.2 Middle East & Africa IVD Infectious Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa IVD Infectious Disease Market Size by Country (2019-2024)
10.4 Middle East & Africa IVD Infectious Disease Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Detail
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics IVD Infectious Disease Introduction
11.1.4 Roche Diagnostics Revenue in IVD Infectious Disease Business (2019-2024)
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories IVD Infectious Disease Introduction
11.2.4 Abbott Laboratories Revenue in IVD Infectious Disease Business (2019-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 Gen-Probe
11.3.1 Gen-Probe Company Detail
11.3.2 Gen-Probe Business Overview
11.3.3 Gen-Probe IVD Infectious Disease Introduction
11.3.4 Gen-Probe Revenue in IVD Infectious Disease Business (2019-2024)
11.3.5 Gen-Probe Recent Development
11.4 Becton Dickinson (BD)
11.4.1 Becton Dickinson (BD) Company Detail
11.4.2 Becton Dickinson (BD) Business Overview
11.4.3 Becton Dickinson (BD) IVD Infectious Disease Introduction
11.4.4 Becton Dickinson (BD) Revenue in IVD Infectious Disease Business (2019-2024)
11.4.5 Becton Dickinson (BD) Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Detail
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories IVD Infectious Disease Introduction
11.5.4 Bio-Rad Laboratories Revenue in IVD Infectious Disease Business (2019-2024)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Siemens Healthcare
11.6.1 Siemens Healthcare Company Detail
11.6.2 Siemens Healthcare Business Overview
11.6.3 Siemens Healthcare IVD Infectious Disease Introduction
11.6.4 Siemens Healthcare Revenue in IVD Infectious Disease Business (2019-2024)
11.6.5 Siemens Healthcare Recent Development
11.7 Biomérieux
11.7.1 Biomérieux Company Detail
11.7.2 Biomérieux Business Overview
11.7.3 Biomérieux IVD Infectious Disease Introduction
11.7.4 Biomérieux Revenue in IVD Infectious Disease Business (2019-2024)
11.7.5 Biomérieux Recent Development
11.8 Danaher
11.8.1 Danaher Company Detail
11.8.2 Danaher Business Overview
11.8.3 Danaher IVD Infectious Disease Introduction
11.8.4 Danaher Revenue in IVD Infectious Disease Business (2019-2024)
11.8.5 Danaher Recent Development
11.9 Thermo Fisher
11.9.1 Thermo Fisher Company Detail
11.9.2 Thermo Fisher Business Overview
11.9.3 Thermo Fisher IVD Infectious Disease Introduction
11.9.4 Thermo Fisher Revenue in IVD Infectious Disease Business (2019-2024)
11.9.5 Thermo Fisher Recent Development
11.10 Sysmex
11.10.1 Sysmex Company Detail
11.10.2 Sysmex Business Overview
11.10.3 Sysmex IVD Infectious Disease Introduction
11.10.4 Sysmex Revenue in IVD Infectious Disease Business (2019-2024)
11.10.5 Sysmex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IVD Infectious Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Biochemical Diagnosis
1.2.3 Immune Diagnosis
1.2.4 Molecular Diagnosis
1.2.5 Microbiological Diagnosis
1.2.6 Urine Diagnosis
1.2.7 Coagulation Diagnosis
1.2.8 Other
1.3 Market by Application
1.3.1 Global IVD Infectious Disease Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Personal
1.3.3 Commercial
1.3.4 Academic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global IVD Infectious Disease Market Perspective (2019-2030)
2.2 IVD Infectious Disease Growth Trends by Region
2.2.1 Global IVD Infectious Disease Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 IVD Infectious Disease Historic Market Size by Region (2019-2024)
2.2.3 IVD Infectious Disease Forecasted Market Size by Region (2025-2030)
2.3 IVD Infectious Disease Market Dynamics
2.3.1 IVD Infectious Disease Industry Trends
2.3.2 IVD Infectious Disease Market Drivers
2.3.3 IVD Infectious Disease Market Challenges
2.3.4 IVD Infectious Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IVD Infectious Disease Players by Revenue
3.1.1 Global Top IVD Infectious Disease Players by Revenue (2019-2024)
3.1.2 Global IVD Infectious Disease Revenue Market Share by Players (2019-2024)
3.2 Global IVD Infectious Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by IVD Infectious Disease Revenue
3.4 Global IVD Infectious Disease Market Concentration Ratio
3.4.1 Global IVD Infectious Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IVD Infectious Disease Revenue in 2023
3.5 IVD Infectious Disease Key Players Head office and Area Served
3.6 Key Players IVD Infectious Disease Product Solution and Service
3.7 Date of Enter into IVD Infectious Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IVD Infectious Disease Breakdown Data by Type
4.1 Global IVD Infectious Disease Historic Market Size by Type (2019-2024)
4.2 Global IVD Infectious Disease Forecasted Market Size by Type (2025-2030)
5 IVD Infectious Disease Breakdown Data by Application
5.1 Global IVD Infectious Disease Historic Market Size by Application (2019-2024)
5.2 Global IVD Infectious Disease Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America IVD Infectious Disease Market Size (2019-2030)
6.2 North America IVD Infectious Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America IVD Infectious Disease Market Size by Country (2019-2024)
6.4 North America IVD Infectious Disease Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe IVD Infectious Disease Market Size (2019-2030)
7.2 Europe IVD Infectious Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe IVD Infectious Disease Market Size by Country (2019-2024)
7.4 Europe IVD Infectious Disease Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific IVD Infectious Disease Market Size (2019-2030)
8.2 Asia-Pacific IVD Infectious Disease Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific IVD Infectious Disease Market Size by Region (2019-2024)
8.4 Asia-Pacific IVD Infectious Disease Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America IVD Infectious Disease Market Size (2019-2030)
9.2 Latin America IVD Infectious Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America IVD Infectious Disease Market Size by Country (2019-2024)
9.4 Latin America IVD Infectious Disease Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IVD Infectious Disease Market Size (2019-2030)
10.2 Middle East & Africa IVD Infectious Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa IVD Infectious Disease Market Size by Country (2019-2024)
10.4 Middle East & Africa IVD Infectious Disease Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Detail
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics IVD Infectious Disease Introduction
11.1.4 Roche Diagnostics Revenue in IVD Infectious Disease Business (2019-2024)
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories IVD Infectious Disease Introduction
11.2.4 Abbott Laboratories Revenue in IVD Infectious Disease Business (2019-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 Gen-Probe
11.3.1 Gen-Probe Company Detail
11.3.2 Gen-Probe Business Overview
11.3.3 Gen-Probe IVD Infectious Disease Introduction
11.3.4 Gen-Probe Revenue in IVD Infectious Disease Business (2019-2024)
11.3.5 Gen-Probe Recent Development
11.4 Becton Dickinson (BD)
11.4.1 Becton Dickinson (BD) Company Detail
11.4.2 Becton Dickinson (BD) Business Overview
11.4.3 Becton Dickinson (BD) IVD Infectious Disease Introduction
11.4.4 Becton Dickinson (BD) Revenue in IVD Infectious Disease Business (2019-2024)
11.4.5 Becton Dickinson (BD) Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Detail
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories IVD Infectious Disease Introduction
11.5.4 Bio-Rad Laboratories Revenue in IVD Infectious Disease Business (2019-2024)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Siemens Healthcare
11.6.1 Siemens Healthcare Company Detail
11.6.2 Siemens Healthcare Business Overview
11.6.3 Siemens Healthcare IVD Infectious Disease Introduction
11.6.4 Siemens Healthcare Revenue in IVD Infectious Disease Business (2019-2024)
11.6.5 Siemens Healthcare Recent Development
11.7 Biomérieux
11.7.1 Biomérieux Company Detail
11.7.2 Biomérieux Business Overview
11.7.3 Biomérieux IVD Infectious Disease Introduction
11.7.4 Biomérieux Revenue in IVD Infectious Disease Business (2019-2024)
11.7.5 Biomérieux Recent Development
11.8 Danaher
11.8.1 Danaher Company Detail
11.8.2 Danaher Business Overview
11.8.3 Danaher IVD Infectious Disease Introduction
11.8.4 Danaher Revenue in IVD Infectious Disease Business (2019-2024)
11.8.5 Danaher Recent Development
11.9 Thermo Fisher
11.9.1 Thermo Fisher Company Detail
11.9.2 Thermo Fisher Business Overview
11.9.3 Thermo Fisher IVD Infectious Disease Introduction
11.9.4 Thermo Fisher Revenue in IVD Infectious Disease Business (2019-2024)
11.9.5 Thermo Fisher Recent Development
11.10 Sysmex
11.10.1 Sysmex Company Detail
11.10.2 Sysmex Business Overview
11.10.3 Sysmex IVD Infectious Disease Introduction
11.10.4 Sysmex Revenue in IVD Infectious Disease Business (2019-2024)
11.10.5 Sysmex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global IVD Infectious Disease Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Biochemical Diagnosis
Table 3. Key Players of Immune Diagnosis
Table 4. Key Players of Molecular Diagnosis
Table 5. Key Players of Microbiological Diagnosis
Table 6. Key Players of Urine Diagnosis
Table 7. Key Players of Coagulation Diagnosis
Table 8. Key Players of Other
Table 9. Global IVD Infectious Disease Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global IVD Infectious Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global IVD Infectious Disease Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global IVD Infectious Disease Market Share by Region (2019-2024)
Table 13. Global IVD Infectious Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global IVD Infectious Disease Market Share by Region (2025-2030)
Table 15. IVD Infectious Disease Market Trends
Table 16. IVD Infectious Disease Market Drivers
Table 17. IVD Infectious Disease Market Challenges
Table 18. IVD Infectious Disease Market Restraints
Table 19. Global IVD Infectious Disease Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global IVD Infectious Disease Market Share by Players (2019-2024)
Table 21. Global Top IVD Infectious Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Disease as of 2023)
Table 22. Ranking of Global Top IVD Infectious Disease Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by IVD Infectious Disease Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players IVD Infectious Disease Product Solution and Service
Table 26. Date of Enter into IVD Infectious Disease Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global IVD Infectious Disease Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global IVD Infectious Disease Revenue Market Share by Type (2019-2024)
Table 30. Global IVD Infectious Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global IVD Infectious Disease Revenue Market Share by Type (2025-2030)
Table 32. Global IVD Infectious Disease Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global IVD Infectious Disease Revenue Market Share by Application (2019-2024)
Table 34. Global IVD Infectious Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global IVD Infectious Disease Revenue Market Share by Application (2025-2030)
Table 36. North America IVD Infectious Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America IVD Infectious Disease Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America IVD Infectious Disease Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe IVD Infectious Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe IVD Infectious Disease Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe IVD Infectious Disease Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific IVD Infectious Disease Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific IVD Infectious Disease Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific IVD Infectious Disease Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America IVD Infectious Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America IVD Infectious Disease Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America IVD Infectious Disease Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa IVD Infectious Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa IVD Infectious Disease Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa IVD Infectious Disease Market Size by Country (2025-2030) & (US$ Million)
Table 51. Roche Diagnostics Company Detail
Table 52. Roche Diagnostics Business Overview
Table 53. Roche Diagnostics IVD Infectious Disease Product
Table 54. Roche Diagnostics Revenue in IVD Infectious Disease Business (2019-2024) & (US$ Million)
Table 55. Roche Diagnostics Recent Development
Table 56. Abbott Laboratories Company Detail
Table 57. Abbott Laboratories Business Overview
Table 58. Abbott Laboratories IVD Infectious Disease Product
Table 59. Abbott Laboratories Revenue in IVD Infectious Disease Business (2019-2024) & (US$ Million)
Table 60. Abbott Laboratories Recent Development
Table 61. Gen-Probe Company Detail
Table 62. Gen-Probe Business Overview
Table 63. Gen-Probe IVD Infectious Disease Product
Table 64. Gen-Probe Revenue in IVD Infectious Disease Business (2019-2024) & (US$ Million)
Table 65. Gen-Probe Recent Development
Table 66. Becton Dickinson (BD) Company Detail
Table 67. Becton Dickinson (BD) Business Overview
Table 68. Becton Dickinson (BD) IVD Infectious Disease Product
Table 69. Becton Dickinson (BD) Revenue in IVD Infectious Disease Business (2019-2024) & (US$ Million)
Table 70. Becton Dickinson (BD) Recent Development
Table 71. Bio-Rad Laboratories Company Detail
Table 72. Bio-Rad Laboratories Business Overview
Table 73. Bio-Rad Laboratories IVD Infectious Disease Product
Table 74. Bio-Rad Laboratories Revenue in IVD Infectious Disease Business (2019-2024) & (US$ Million)
Table 75. Bio-Rad Laboratories Recent Development
Table 76. Siemens Healthcare Company Detail
Table 77. Siemens Healthcare Business Overview
Table 78. Siemens Healthcare IVD Infectious Disease Product
Table 79. Siemens Healthcare Revenue in IVD Infectious Disease Business (2019-2024) & (US$ Million)
Table 80. Siemens Healthcare Recent Development
Table 81. Biomérieux Company Detail
Table 82. Biomérieux Business Overview
Table 83. Biomérieux IVD Infectious Disease Product
Table 84. Biomérieux Revenue in IVD Infectious Disease Business (2019-2024) & (US$ Million)
Table 85. Biomérieux Recent Development
Table 86. Danaher Company Detail
Table 87. Danaher Business Overview
Table 88. Danaher IVD Infectious Disease Product
Table 89. Danaher Revenue in IVD Infectious Disease Business (2019-2024) & (US$ Million)
Table 90. Danaher Recent Development
Table 91. Thermo Fisher Company Detail
Table 92. Thermo Fisher Business Overview
Table 93. Thermo Fisher IVD Infectious Disease Product
Table 94. Thermo Fisher Revenue in IVD Infectious Disease Business (2019-2024) & (US$ Million)
Table 95. Thermo Fisher Recent Development
Table 96. Sysmex Company Detail
Table 97. Sysmex Business Overview
Table 98. Sysmex IVD Infectious Disease Product
Table 99. Sysmex Revenue in IVD Infectious Disease Business (2019-2024) & (US$ Million)
Table 100. Sysmex Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IVD Infectious Disease Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global IVD Infectious Disease Market Share by Type: 2023 VS 2030
Figure 3. Biochemical Diagnosis Features
Figure 4. Immune Diagnosis Features
Figure 5. Molecular Diagnosis Features
Figure 6. Microbiological Diagnosis Features
Figure 7. Urine Diagnosis Features
Figure 8. Coagulation Diagnosis Features
Figure 9. Other Features
Figure 10. Global IVD Infectious Disease Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global IVD Infectious Disease Market Share by Application: 2023 VS 2030
Figure 12. Personal Case Studies
Figure 13. Commercial Case Studies
Figure 14. Academic Case Studies
Figure 15. Other Case Studies
Figure 16. IVD Infectious Disease Report Years Considered
Figure 17. Global IVD Infectious Disease Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global IVD Infectious Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global IVD Infectious Disease Market Share by Region: 2023 VS 2030
Figure 20. Global IVD Infectious Disease Market Share by Players in 2023
Figure 21. Global Top IVD Infectious Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Disease as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by IVD Infectious Disease Revenue in 2023
Figure 23. North America IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America IVD Infectious Disease Market Share by Country (2019-2030)
Figure 25. United States IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe IVD Infectious Disease Market Share by Country (2019-2030)
Figure 29. Germany IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific IVD Infectious Disease Market Share by Region (2019-2030)
Figure 37. China IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America IVD Infectious Disease Market Share by Country (2019-2030)
Figure 45. Mexico IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa IVD Infectious Disease Market Share by Country (2019-2030)
Figure 49. Turkey IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Roche Diagnostics Revenue Growth Rate in IVD Infectious Disease Business (2019-2024)
Figure 52. Abbott Laboratories Revenue Growth Rate in IVD Infectious Disease Business (2019-2024)
Figure 53. Gen-Probe Revenue Growth Rate in IVD Infectious Disease Business (2019-2024)
Figure 54. Becton Dickinson (BD) Revenue Growth Rate in IVD Infectious Disease Business (2019-2024)
Figure 55. Bio-Rad Laboratories Revenue Growth Rate in IVD Infectious Disease Business (2019-2024)
Figure 56. Siemens Healthcare Revenue Growth Rate in IVD Infectious Disease Business (2019-2024)
Figure 57. Biomérieux Revenue Growth Rate in IVD Infectious Disease Business (2019-2024)
Figure 58. Danaher Revenue Growth Rate in IVD Infectious Disease Business (2019-2024)
Figure 59. Thermo Fisher Revenue Growth Rate in IVD Infectious Disease Business (2019-2024)
Figure 60. Sysmex Revenue Growth Rate in IVD Infectious Disease Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global IVD Infectious Disease Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Biochemical Diagnosis
Table 3. Key Players of Immune Diagnosis
Table 4. Key Players of Molecular Diagnosis
Table 5. Key Players of Microbiological Diagnosis
Table 6. Key Players of Urine Diagnosis
Table 7. Key Players of Coagulation Diagnosis
Table 8. Key Players of Other
Table 9. Global IVD Infectious Disease Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global IVD Infectious Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global IVD Infectious Disease Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global IVD Infectious Disease Market Share by Region (2019-2024)
Table 13. Global IVD Infectious Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global IVD Infectious Disease Market Share by Region (2025-2030)
Table 15. IVD Infectious Disease Market Trends
Table 16. IVD Infectious Disease Market Drivers
Table 17. IVD Infectious Disease Market Challenges
Table 18. IVD Infectious Disease Market Restraints
Table 19. Global IVD Infectious Disease Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global IVD Infectious Disease Market Share by Players (2019-2024)
Table 21. Global Top IVD Infectious Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Disease as of 2023)
Table 22. Ranking of Global Top IVD Infectious Disease Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by IVD Infectious Disease Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players IVD Infectious Disease Product Solution and Service
Table 26. Date of Enter into IVD Infectious Disease Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global IVD Infectious Disease Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global IVD Infectious Disease Revenue Market Share by Type (2019-2024)
Table 30. Global IVD Infectious Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global IVD Infectious Disease Revenue Market Share by Type (2025-2030)
Table 32. Global IVD Infectious Disease Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global IVD Infectious Disease Revenue Market Share by Application (2019-2024)
Table 34. Global IVD Infectious Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global IVD Infectious Disease Revenue Market Share by Application (2025-2030)
Table 36. North America IVD Infectious Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America IVD Infectious Disease Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America IVD Infectious Disease Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe IVD Infectious Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe IVD Infectious Disease Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe IVD Infectious Disease Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific IVD Infectious Disease Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific IVD Infectious Disease Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific IVD Infectious Disease Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America IVD Infectious Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America IVD Infectious Disease Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America IVD Infectious Disease Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa IVD Infectious Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa IVD Infectious Disease Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa IVD Infectious Disease Market Size by Country (2025-2030) & (US$ Million)
Table 51. Roche Diagnostics Company Detail
Table 52. Roche Diagnostics Business Overview
Table 53. Roche Diagnostics IVD Infectious Disease Product
Table 54. Roche Diagnostics Revenue in IVD Infectious Disease Business (2019-2024) & (US$ Million)
Table 55. Roche Diagnostics Recent Development
Table 56. Abbott Laboratories Company Detail
Table 57. Abbott Laboratories Business Overview
Table 58. Abbott Laboratories IVD Infectious Disease Product
Table 59. Abbott Laboratories Revenue in IVD Infectious Disease Business (2019-2024) & (US$ Million)
Table 60. Abbott Laboratories Recent Development
Table 61. Gen-Probe Company Detail
Table 62. Gen-Probe Business Overview
Table 63. Gen-Probe IVD Infectious Disease Product
Table 64. Gen-Probe Revenue in IVD Infectious Disease Business (2019-2024) & (US$ Million)
Table 65. Gen-Probe Recent Development
Table 66. Becton Dickinson (BD) Company Detail
Table 67. Becton Dickinson (BD) Business Overview
Table 68. Becton Dickinson (BD) IVD Infectious Disease Product
Table 69. Becton Dickinson (BD) Revenue in IVD Infectious Disease Business (2019-2024) & (US$ Million)
Table 70. Becton Dickinson (BD) Recent Development
Table 71. Bio-Rad Laboratories Company Detail
Table 72. Bio-Rad Laboratories Business Overview
Table 73. Bio-Rad Laboratories IVD Infectious Disease Product
Table 74. Bio-Rad Laboratories Revenue in IVD Infectious Disease Business (2019-2024) & (US$ Million)
Table 75. Bio-Rad Laboratories Recent Development
Table 76. Siemens Healthcare Company Detail
Table 77. Siemens Healthcare Business Overview
Table 78. Siemens Healthcare IVD Infectious Disease Product
Table 79. Siemens Healthcare Revenue in IVD Infectious Disease Business (2019-2024) & (US$ Million)
Table 80. Siemens Healthcare Recent Development
Table 81. Biomérieux Company Detail
Table 82. Biomérieux Business Overview
Table 83. Biomérieux IVD Infectious Disease Product
Table 84. Biomérieux Revenue in IVD Infectious Disease Business (2019-2024) & (US$ Million)
Table 85. Biomérieux Recent Development
Table 86. Danaher Company Detail
Table 87. Danaher Business Overview
Table 88. Danaher IVD Infectious Disease Product
Table 89. Danaher Revenue in IVD Infectious Disease Business (2019-2024) & (US$ Million)
Table 90. Danaher Recent Development
Table 91. Thermo Fisher Company Detail
Table 92. Thermo Fisher Business Overview
Table 93. Thermo Fisher IVD Infectious Disease Product
Table 94. Thermo Fisher Revenue in IVD Infectious Disease Business (2019-2024) & (US$ Million)
Table 95. Thermo Fisher Recent Development
Table 96. Sysmex Company Detail
Table 97. Sysmex Business Overview
Table 98. Sysmex IVD Infectious Disease Product
Table 99. Sysmex Revenue in IVD Infectious Disease Business (2019-2024) & (US$ Million)
Table 100. Sysmex Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IVD Infectious Disease Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global IVD Infectious Disease Market Share by Type: 2023 VS 2030
Figure 3. Biochemical Diagnosis Features
Figure 4. Immune Diagnosis Features
Figure 5. Molecular Diagnosis Features
Figure 6. Microbiological Diagnosis Features
Figure 7. Urine Diagnosis Features
Figure 8. Coagulation Diagnosis Features
Figure 9. Other Features
Figure 10. Global IVD Infectious Disease Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global IVD Infectious Disease Market Share by Application: 2023 VS 2030
Figure 12. Personal Case Studies
Figure 13. Commercial Case Studies
Figure 14. Academic Case Studies
Figure 15. Other Case Studies
Figure 16. IVD Infectious Disease Report Years Considered
Figure 17. Global IVD Infectious Disease Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global IVD Infectious Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global IVD Infectious Disease Market Share by Region: 2023 VS 2030
Figure 20. Global IVD Infectious Disease Market Share by Players in 2023
Figure 21. Global Top IVD Infectious Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Disease as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by IVD Infectious Disease Revenue in 2023
Figure 23. North America IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America IVD Infectious Disease Market Share by Country (2019-2030)
Figure 25. United States IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe IVD Infectious Disease Market Share by Country (2019-2030)
Figure 29. Germany IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific IVD Infectious Disease Market Share by Region (2019-2030)
Figure 37. China IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America IVD Infectious Disease Market Share by Country (2019-2030)
Figure 45. Mexico IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa IVD Infectious Disease Market Share by Country (2019-2030)
Figure 49. Turkey IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia IVD Infectious Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Roche Diagnostics Revenue Growth Rate in IVD Infectious Disease Business (2019-2024)
Figure 52. Abbott Laboratories Revenue Growth Rate in IVD Infectious Disease Business (2019-2024)
Figure 53. Gen-Probe Revenue Growth Rate in IVD Infectious Disease Business (2019-2024)
Figure 54. Becton Dickinson (BD) Revenue Growth Rate in IVD Infectious Disease Business (2019-2024)
Figure 55. Bio-Rad Laboratories Revenue Growth Rate in IVD Infectious Disease Business (2019-2024)
Figure 56. Siemens Healthcare Revenue Growth Rate in IVD Infectious Disease Business (2019-2024)
Figure 57. Biomérieux Revenue Growth Rate in IVD Infectious Disease Business (2019-2024)
Figure 58. Danaher Revenue Growth Rate in IVD Infectious Disease Business (2019-2024)
Figure 59. Thermo Fisher Revenue Growth Rate in IVD Infectious Disease Business (2019-2024)
Figure 60. Sysmex Revenue Growth Rate in IVD Infectious Disease Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Camelina Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Bentgrass Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Barley Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232